Lenalidomide + Rituximab
From OncoWiki
Jump to navigationJump to search
Chronic Lymphocytic Leukemia
- Lenalidomide (Revlimid) 25 mg po qd d1-21
- Rituximab (Rituxan) 375 mg/m2 iv d1, 8 and 15 of cycle 1, then d1 and 15 of cycles 2-6
Q4w